Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study

Annals of Medicine

Volumn 44, Issue 2, 2012, Pages 170-177

  Rathmann, Wolfgang ^a   Kowall, Bernd ^a   Tamayo, Teresa ^a   Giani, Guido ^a   Holle, Rolf ^b   Thorand, Barbara ^b   Heier, Margit ^b   Huth, Cornelia ^b   Meisinger, Christa ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Glycosylated hemoglobin A; impaired fasting glucose; impaired glucose tolerance; normal glucose tolerance; oral glucose tolerance test; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN ANALYSIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICIPANT OBSERVATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; GLUCOSE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84857735644     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.531759     Document Type: Article

References (22)

1. World Health Organization. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications. Part 1: Diagnosis and classifi cation of diabetes mellitus. Report of a WHO consultation. Geneva: World Health Organization; 1999.
2. Borch-Johnsen K, Colagiuri S. Diagnosing diabetes-time for a change? Diabetologia. 2009;52:2247-50.
3. Consensus Committee. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007; 30:2399-400.
4. American Diabetes Association. Standards of Medical Care in Diabetes-2010. Diabetes Care. 2010;33:S11-61.
5. International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34.
6. Christensen DL, Witte DR, Kaduka L, J ør gensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580-2.
7. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87:415-21.
8. Rathmann W, Haastert B, Icks A, Lö w el H, Meisinger C, Holle R, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for effi cient screening . The KORA survey 2000. Diabetologia. 2003;46: 182-9.
9. Van 't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population. The New Hoorn Study. Diabetes Care. 2010;33:61-6.
10. Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care. 2010;33:101-3.
11. Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F, et al. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and prediabetes defi ned by an oral glucose tolerance test in Quingdao, China. Diabetes Care. 2010;33:545-50.
12. Lorenzo C, Haffner SM. Performance characteristics of the new defi nition of diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2010;33:335-7.
13. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the US population in 1988-2006. Diabetes Care. 2010;33:562-8.
14. Bennett CM, Guo M, Dharmage SC. HbA1C as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007;24:333-43.
15. Buell C, Kermah D, Davidson MB. Utility of A1C for Diabetes Screening in the 1999-2004 NHANES population. Diabetes Care. 2007;30:2233-5.
16. Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, et al. A1C cut points to defi ne various glucose intolerance groups in Asian Indians. Diabetes Care. 2010;33:515-9.
17. Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care. 2010;33:2104-9.
18. M annucci E, Ognibene A, Sposato I , Brogi M, Gallori G, Bardini G, et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol. 2003;40:181-6.
19. Tuomilehto J, Lindströ m J, Eriksson JG, Valle TT, Hä m ä l äi nen H, Ilanne-Parikka P, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
20. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
21. Borg R, Vistisen D, Witte DR, Borch-Johnsen K. Comparing risk profi les of individuals diagnosed by OGTT and HbA1c. Diabet Med. 2010;27:906-10.
22. Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J, et al. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus. Diabet Med. 2010;27:762-9.